Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide in Biochemically Recurrent, Hormone Naive Prostate Cancer
NCT00080899Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2004
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenretinide in prostate cancer (PCa), sponsored by National Cancer Institute. Started Jun 2004; status: completed.
02
Drugs
fenretinide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00080899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080899.